Hiberix (GlaxoSmithKline Biologicals SA)
Welcome to the PulseAid listing for the Hiberix drug offered from GlaxoSmithKline Biologicals SA. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline Biologicals SA |
| NON-PROPRIETARY NAME: | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
| SUBSTANCE NAME: | |
| TYPE: | VACCINE |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-12-21 |
| END MARKETING DATE: | 0000-00-00 |
Hiberix VACCINE Details:
| Item Description | Hiberix from GlaxoSmithKline Biologicals SA |
| LABELER NAME: | GlaxoSmithKline Biologicals SA |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2015-12-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58160-818_f7ebe494-1728-47db-b502-b088a8dc3113 |
| PRODUCT NDC: | 58160-818 |
| APPLICATION NUMBER: | BLA125347 |